مدرنا (Persian Wikipedia)

ایران، عصر (۱۴۰۲/۱۰/۱۹ - ۰۱:۳۰). «برنامه‌های شرکت «مُدرنا» برای تولید واکسن». fa. دریافت‌شده در 2024-01-12. تاریخ وارد شده در |تاریخ= را بررسی کنید (کمک)

biospace.com

Mark Terry (January 12, 2016). "Booming Moderna Eyes Six Human Trials in 2016, Inks Deals with AstraZeneca PLC (AZN), Merck & Co. (MRK) and Signed Huge Lease in Cambridge for R&D Growth". Biospace. Archived from the original on 27 November 2016. Retrieved 18 March 2020.

bioworld.com

Catherine Shaffer (December 6, 2013). "Moderna Makes Entrance with $40M Round for mRNA Work". BioWorld. Retrieved 17 March 2020.
Karen Carey (February 26, 2020). "Increasing number of biopharma drugs target COVID-19 as virus spreads". BioWorld. Retrieved 18 March 2020.

bizjournals.com

Alspach, Kyle (May 22, 2013). "Moderna CEO Bancel joins Flagship Ventures as senior partner". Boston Business Journal (Blog). American City Business Journals. Retrieved March 17, 2020.

boston.com

Reidy, Chris. "Alexion, Moderna announce agreement to develop messenger RNA therapeutics. Boston Globe. January 13, 2014.

bostonglobe.com

Michael Farrell (December 6, 2012). "New Cambridge biotech comes out of stealth mode". Boston Globe. Retrieved 18 March 2020.
Robert Weisman (March 21, 2013). "Moderna in line for $240m licensing deal". The Boston Globe. Retrieved March 18, 2020.

bostonmagazine.com

Catherine Elton (March 2013). "The NEXT Next Big Thing". Boston Magazine. Archived from the original on 16 November 2020. Retrieved March 18, 2020.

businessinsider.com

markets.businessinsider.com

Gwen Everett (February 27, 2020). "These 5 drug developers have jumped this week on hopes they can provide a coronavirus treatment". Markets Insider. Retrieved 18 March 2020.

endpts.com

John Carroll (July 6, 2016). "Trendy Moderna's single-asset CF pact with Vertex marks a , new phase of dealmaking". Endpoints. Retrieved 18 March 2020.
John Carroll (September 21, 2016). "Biotech unicorn Moderna gambles $110M on a groundbreaking mRNA manufacturing facility, blueprints plant #2". Endpoints. Retrieved 18 March 2020.

fiercebiotech.com

Emily Mullin (October 2, 2013). "Moderna lands $25M grant to develop its RNA platform against infectious diseases, bioterror". Fierce Biotech. Retrieved 18 March 2020.
Stacy Lawrence (June 29, 2016). "Merck, Moderna tie up in $200M deal to develop mRNA-based 'personalized' cancer vaccines". FierceBiotech. Retrieved 18 March 2020.
Adams, Ben (September 14, 2017). "Moderna changes up R&D model, posts cancer, CV trial updates". FierceBiotech (به انگلیسی).

fiercepharma.com

Eric Palmer (September 21, 2016). "Moderna lays out ambitious $110M facility for clinical supplies". FierceBiotech. Retrieved 18 March 2020.

fortune.com

Term Sheet: Tik-Tok, Fortune

ft.com

Crow, David (7 September 2017). "Moderna pledge sets investor pulses racing; Biotech group promises to rewrite rules of drug development – though sceptics say $5bn valuation is undeserved". Financial Times.

genengnews.com

GEN (September 7, 2016). "Moderna Wins Up to $125M from BARDA toward Zika mRNA Vaccine". Genetic Engineering & Biotechnology News. Retrieved 18 March 2020.
GEN (September 7, 2016). "Moderna Wins Up to $125M from BARDA toward Zika mRNA Vaccine". Genetic Engineering & Biotechnology News. Retrieved 18 March 2020.

modernatx.com

Press release. "Moderna to Collaborate with Karolinska Institutet and Karolinska University Hospital on Discovery of New Messenger RNA Therapeutics بایگانی‌شده در ۲۹ نوامبر ۲۰۱۴ توسط Wayback Machine. October 16, 2014.
Press release. "Moderna Closes $450 Million Financing to Support Growth of Messenger RNA Therapeutics Platform across Diverse Therapeutic Areas" بایگانی‌شده در ۲۳ دسامبر ۲۰۱۶ توسط Wayback Machine. January 5, 2015.
Press release. "Moderna Launches New Venture Valera LLC for Infectious Diseases" بایگانی‌شده در ۲۱ دسامبر ۲۰۱۶ توسط Wayback Machine. January 8, 2015.
Press release. "Moderna Announces License and Collaboration Agreement with Merck to Develop Messenger RNA-based Antiviral Vaccines and Passive Immunity Therapies" بایگانی‌شده در ۲۰ دسامبر ۲۰۱۶ توسط Wayback Machine. January 13, 2015.
Press release. "Moderna Launches Third Venture Company Elpidera for Rare Diseases" بایگانی‌شده در ۱۷ مه ۲۰۱۵ توسط Wayback Machine. May 12, 2015.

nytimes.com

Andrew Pollack (March 21, 2013). "AstraZeneca Makes a Bet on an Untested Technique". New York Times. Retrieved 18 March 2020.

pharmamedtechbi.com

scrip.pharmamedtechbi.com

Sten Stovall (January 11, 2016). "AstraZeneca Ups Betting Ante On Moderna's Messenger RNA Technology". Scrip. Archived from the original on 27 November 2016. Retrieved 18 March 2020.

reuters.com

Julie Steenhuysen, Kate Kelland (2020-01-24). "With Wuhan virus genetic code in hand, scientists begin work on a vaccine". Reuters (به انگلیسی). Retrieved 2020-03-18.{{cite news}}: نگهداری یادکرد:استفاده از پارامتر نویسندگان (link)

web.archive.org

Catherine Elton (March 2013). "The NEXT Next Big Thing". Boston Magazine. Archived from the original on 16 November 2020. Retrieved March 18, 2020.
"The Daily Startup: Moderna to Advance Messenger RNA Therapies Privately, Despite IPO Market". The Wall Street Journal. Nov 20, 2013. Archived from the original on 28 February 2020. Retrieved 18 March 2020.
Press release. "Moderna to Collaborate with Karolinska Institutet and Karolinska University Hospital on Discovery of New Messenger RNA Therapeutics بایگانی‌شده در ۲۹ نوامبر ۲۰۱۴ توسط Wayback Machine. October 16, 2014.
Press release. "Moderna Closes $450 Million Financing to Support Growth of Messenger RNA Therapeutics Platform across Diverse Therapeutic Areas" بایگانی‌شده در ۲۳ دسامبر ۲۰۱۶ توسط Wayback Machine. January 5, 2015.
Press release. "Moderna Launches New Venture Valera LLC for Infectious Diseases" بایگانی‌شده در ۲۱ دسامبر ۲۰۱۶ توسط Wayback Machine. January 8, 2015.
Press release. "Moderna Announces License and Collaboration Agreement with Merck to Develop Messenger RNA-based Antiviral Vaccines and Passive Immunity Therapies" بایگانی‌شده در ۲۰ دسامبر ۲۰۱۶ توسط Wayback Machine. January 13, 2015.
Press release. "Moderna Launches Third Venture Company Elpidera for Rare Diseases" بایگانی‌شده در ۱۷ مه ۲۰۱۵ توسط Wayback Machine. May 12, 2015.
Sten Stovall (January 11, 2016). "AstraZeneca Ups Betting Ante On Moderna's Messenger RNA Technology". Scrip. Archived from the original on 27 November 2016. Retrieved 18 March 2020.
Mark Terry (January 12, 2016). "Booming Moderna Eyes Six Human Trials in 2016, Inks Deals with AstraZeneca PLC (AZN), Merck & Co. (MRK) and Signed Huge Lease in Cambridge for R&D Growth". Biospace. Archived from the original on 27 November 2016. Retrieved 18 March 2020.

wsj.com

blogs.wsj.com

"The Daily Startup: Moderna to Advance Messenger RNA Therapies Privately, Despite IPO Market". The Wall Street Journal. Nov 20, 2013. Archived from the original on 28 February 2020. Retrieved 18 March 2020.

xconomy.com

Kutz, Erin (4 October 2010). "ModeRNA, Stealth Startup Backed By Flagship, Unveils New Way to Make Stem Cells". Xconomy.
Gregory Huang (December 6, 2012). "Moderna, $40M in Tow, Hopes to Reinvent Biotech with "Make Your Own Drug"". Xconomy.
Luke Timmerman (October 2, 2013). "Moderna Snags $25M DARPA Grant to Fight Pandemics With mRNA Drugs". Xconomy. Retrieved March 18, 2020.
Ben Fidler (October 22, 2015). "With New Startup, Caperna, Moderna Gets in on Cancer Vaccine Buzz". Xconomy. Retrieved 18 March 2020.